← Back to Sector Map

HSIC

Health Care · Health Care Distributors

HENRY SCHEIN INC

$75.36

+0.68%

AI Research

Q4 revenue +7.7% to $3.44B beats estimates; FY2026 EPS guided $5.23-$5.37

NeutralHoldPT $85.58

Henry Schein reported Q4 2025 revenue of $3.44B (+7.7% YoY), beating the $3.34B estimate, with EPS of $1.34 topping the $1.30 consensus by $0.04. The company set FY2026 guidance at $5.23-$5.37 EPS, and the consensus analyst recommendation is "Hold" with 13 analysts covering the stock and an average 12-month target of $85.58. The stock recently dipped to $75.57 following post-earnings retreat, though near-term catalysts remain supportive of the dental supply and distribution business.

Key Stats

Market Cap$8.8B
P/E (TTM)22.8
Fwd P/E12.6
Beta0.85
Div Yield
Prev Close$74.85

52-Week Range

$60.56$75.36$89.29